Erick DeVinney
Corporate Officer/Principal at AXOGEN, INC.
Net worth: 1 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gregory Freitag | M | 62 | 14 years | |
| Karen Zaderej | F | 62 | 18 years | |
| Marc Began | M | 57 | 1 years | |
| Victor Manuel Diaz | M | 64 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 17 years |
| Paul Thomas | M | 68 | 4 years | |
| Amy McBride-Wendell | F | 63 | 8 years | |
| Joseph Tyndall | M | 55 | 2 years | |
| Stacy Arnold | F | - | 6 years | |
| William Burke | M | 55 | 2 years | |
| Alan Levine | M | 63 | 5 years | |
| Guido Neels | M | 75 | 9 years | |
| John Johnson | M | 66 | 3 years | |
| Jens Kemp | M | - | 1 years | |
| Doris Quackenbush | F | - | 2 years | |
| Kathy Weiler | F | 55 | 1 years | |
| Nir Naor | M | 50 | 1 years | |
| Todd Puckett | M | - | - | |
| Ivica Ducic | M | - | 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jamie M. Grooms | M | 64 |
AxoGen Corp.
 AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | 17 years |
| Joseph Mandato | M | 80 |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | 10 years |
| John Frederick Harper | M | 73 |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | 4 years |
| Tammy Neske | F | 53 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | - |
| John P. Engels | M | 52 |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | 16 years |
| Mark Gold | M | 75 |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | 11 years |
| David K. Hansen | M | 62 |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | 15 years |
| Kasra Hedayatnia | M | - |
Virginia Commonwealth University
| 5 years |
| Michael Donovan | M | 59 |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | 13 years |
| Peter Mariani | M | 60 | 7 years | |
| Jerry Chang | M | - |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | - |
| Robert Rudelius | M | 68 | 10 years | |
| Quentin Blackford | M | 46 | 3 years | |
| Brad Jay Hedger | M | 62 |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | - |
| Gary Ingenito | M | 68 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 3 years |
| Mark Owens Thornton | M | 66 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 1 years |
| Alistair Ersksine | M | - |
Virginia Commonwealth University
| 4 years |
| Bradley L. Ottinger | M | 54 | 3 years | |
| Isabelle Billet | F | 62 | 5 years | |
| Yonas Hunegnaw | M | - |
Virginia Commonwealth University
| 4 years |
| Steven T. Liu | M | - |
Virginia Commonwealth University
| 3 years |
| Thomas O'Neil | M | - |
Virginia Commonwealth University
| 4 years |
| Monica L. Tarver | F | - | - | |
| Marlo Tan Walpole | F | - | - | |
| Chris Shelton | M | - |
Virginia Commonwealth University
| 4 years |
| Katheryn B. Curtis | F | - |
Virginia Commonwealth University
| 4 years |
| Jessica Popp | F | - |
Virginia Commonwealth University
| 1 years |
| Kristy Bruse | M | - |
Virginia Commonwealth University
| 3 years |
| Jodi Regts | F | - |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 3 years |
| Jon S. Gingrich | M | 55 | 2 years | |
| Kaila Krum | F | - | 1 years | |
| Kishau Rogers | M | - |
Virginia Commonwealth University
| 5 years |
| Nousheen Huq | F | 53 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 7 years |
| Christopher Crisman | M | - | 3 years | |
| John T. Caldwell | M | - |
Virginia Commonwealth University
| 1 years |
| Angelo Scopelianos | M | 69 | 6 years | |
| Paige Clay | F | - |
Virginia Commonwealth University
| 2 years |
| Maria Martinez | F | 56 | 5 years | |
| James Bryan Hart | M | - |
Virginia Commonwealth University
| 3 years |
| Kevin Leach | M | 54 | - | |
| Brandon Christopher Taylor | M | - |
Virginia Commonwealth University
| 4 years |
| Gregory Davault | M | - | 5 years | |
| Ross E. Sallade | M | - |
Virginia Commonwealth University
| 1 years |
| Erik de Vries | M | - |
Virginia Commonwealth University
| 2 years |
| Lisa Colleran | F | 66 | - | |
| Pamela Kiecker Royall | M | - |
Virginia Commonwealth University
| 6 years |
| Philip Toleikis | M | - |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 7 years |
| Jonathan W. Chen | M | 49 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 6 years |
| Mark Louis Friedman | M | 66 | 16 years | |
| Ernest A. Carabillo | M | - |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | - |
| Shawn F. McCarrey | M | 66 | 6 years | |
| John McLaughlin | M | 72 | 2 years | |
| Robert Fillmore Norfleet | M | - |
Virginia Commonwealth University
| 2 years |
| Alan Clark Ashworth | M | - |
Virginia Commonwealth University
| 1 years |
| Matt McCall | M | - |
Virginia Commonwealth University
| 1 years |
| Cathy Temple | F | - |
Virginia Commonwealth University
| 2 years |
| Lisa Tatum | F | 56 |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | - |
| Greg Peet | M | 70 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 3 years |
| Shannon Michelle Hughes | F | - |
Virginia Commonwealth University
| 4 years |
| Laura Brege | F | 66 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 4 years |
| David M. Gravett | M | 58 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | 3 years |
| Gerard van Hamel Platerink | M | 55 |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | - |
| Lee Robert Johnston | M | 63 | 1 years | |
| Cari Brunelle | F | - |
Virginia Commonwealth University
| 4 years |
| Stephen Michael Loderick | M | - |
Virginia Commonwealth University
| 2 years |
| Kevin Stewart Rutherford | M | - |
Virginia Commonwealth University
| 3 years |
| Artem Sirazutdinov | M | 55 |
Virginia Commonwealth University
| 2 years |
| Jay Bernard Dent | M | 65 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | - |
| Jeffrey P. Walker | M | 72 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | - |
| Clater C. Mottinger | M | - |
Virginia Commonwealth University
| 2 years |
| Eric Sandberg | M | 59 | 3 years | |
| Bill Gregory | M | - |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The private company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | - |
| Christopher M. Grandpre | M | - |
Virginia Commonwealth University
| 1 years |
| Talgat Irisbekov | M | - |
Virginia Commonwealth University
| 4 years |
| Brian J. Miller | M | - |
Virginia Commonwealth University
| 2 years |
| Ursula N. Butts | F | - |
Virginia Commonwealth University
| 1 years |
| Jill Schiaparelli | F | 58 | 3 years | |
| Diane Leopold | F | 57 |
Virginia Commonwealth University
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 83 | 86.46% |
| Canada | 13 | 13.54% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Erick DeVinney
- Personal Network
